Michael Hayden
2016
In 2016, Michael Hayden earned a total compensation of $7.5M as Former President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical Industries, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Non-Equity Incentive Plan | $970,202 |
| Option Awards | $1,150,055 |
| Salary | $1,071,000 |
| Stock Awards | $1,149,956 |
| Other | $2,638,012 |
| Total | $7,479,225 |
Hayden received $2.6M in other compensation, accounting for 35% of the total pay in 2016.
Hayden also received $500K in bonus, $970.2K in non-equity incentive plan, $1.2M in option awards, $1.1M in salary and $1.1M in stock awards.
Rankings
In 2016, Michael Hayden's compensation ranked 834th out of 14,075 executives tracked by ExecPay. In other words, Hayden earned more than 94.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 834 out of 14,075 | 94th |
Division Manufacturing | 271 out of 5,489 | 95th |
Major group Chemicals And Allied Products | 69 out of 1,895 | 96th |
Industry group Drugs | 47 out of 1,538 | 97th |
Industry Pharmaceutical Preparations | 39 out of 1,176 | 97th |
Source: SEC filing on April 25, 2018.
Hayden's colleagues
We found three more compensation records of executives who worked with Michael Hayden at Teva Pharmaceutical Industries in 2016.